Markus Guba

11.9k total citations · 3 hit papers
194 papers, 8.5k citations indexed

About

Markus Guba is a scholar working on Surgery, Hepatology and Oncology. According to data from OpenAlex, Markus Guba has authored 194 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Surgery, 70 papers in Hepatology and 59 papers in Oncology. Recurrent topics in Markus Guba's work include Organ Transplantation Techniques and Outcomes (52 papers), Liver Disease and Transplantation (44 papers) and Renal Transplantation Outcomes and Treatments (37 papers). Markus Guba is often cited by papers focused on Organ Transplantation Techniques and Outcomes (52 papers), Liver Disease and Transplantation (44 papers) and Renal Transplantation Outcomes and Treatments (37 papers). Markus Guba collaborates with scholars based in Germany, United States and China. Markus Guba's co-authors include Christiane J. Bruns, Karl‐Walter Jauch, Christopher Heeschen, Patrick Hermann, Stephan Huber, Tanja Herrler, Alexandra Aicher, Joachim W. Ellwart, Edward K. Geissler and Markus Steinbauer and has published in prestigious journals such as Nature Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Markus Guba

186 papers receiving 8.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Distinct Populations of Cancer Stem Cells Determine Tumor Growth and Metastatic Activity in Human Pancreatic Cancer

2007 2.2k citations Patrick Hermann, Stephan Huber et al. profile →
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

2002 1.4k citations Markus Guba, Christiane J. Bruns et al. profile →
The Role of Gut-Derived Lipopolysaccharides and the Intestinal Barrier in Fatty Liver Diseases

2021 162 citations Dominik Koch, Malte Schirren et al. profile →

Peers

Countries citing papers authored by Markus Guba

Since Specialization

Citations

This map shows the geographic impact of Markus Guba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Guba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Guba more than expected).

Fields of papers citing papers by Markus Guba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Guba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Guba. The network helps show where Markus Guba may publish in the future.

Co-authorship network of co-authors of Markus Guba

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Guba. A scholar is included among the top collaborators of Markus Guba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Guba. Markus Guba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	TRANSMIT: Utilizing discarded livers from donors with a history of cancer for patients lacking access to standard allocation - A compassionate use exploratory study 2025 ·Contemporary Clinical Trials Communications ·Dominik Koch, Malte Schirren, (unknown), Christian M. Lange, (unknown), Dionysios Koliogiannis, Markus Guba	0
2	Liver transplantation in Candida endocarditis–induced acute-on-chronic liver failure 2025 ·American Journal of Transplantation ·(unknown), (unknown), (unknown), Manfred Stangl, Felix Kur, Markus Guba, Jan Melichar, Michael Irlbeck, Rika Draenert, (unknown)	0
3	Mono-HOPE Versus Dual-HOPE in Liver Transplantation: A Propensity Score-Matched Evaluation of Early Graft Outcome 2025 ·Transplant International ·Dominik Koch, Mami Tamai, Malte Schirren, Moritz Drefs, (unknown), Christian M. Lange, Matthias Ilmer, Hanno Nieß, Bernhard W. Renz, (unknown), Markus Guba, Dionysios Koliogiannis	4
4	Bots in white coats: are large language models the future of patient education? A multicenter cross-sectional analysis 2025 ·International Journal of Surgery ·(unknown), (unknown), (unknown), (unknown), Michael Thomas, Thomas Schmidt, Christian Krautz, Christoph Kahlert, Sebastian Schölch, Martin K. Angele, Hanno Nieß, Markus Guba, Jens Werner, Matthias Ilmer, Bernhard W. Renz	4
5	Deep Learning-Adjusted Monitoring of In-Hospital Mortality after Liver Transplantation 2024 ·Journal of Clinical Medicine ·Nikolaus Börner, Markus Bo Schoenberg, (unknown), (unknown), Christian Böhm, Dominik Koch, Moritz Drefs, Dionysios Koliogiannis, Joachim Andrassy, Jens Werner, Markus Guba	1
6	Impact of Hypothermic Oxygenated Machine Perfusion on Immune Cell Clearance in Liver Transplantation: Enhancing Graft Function and Post-Transplant Outcomes 2024 ·Journal of Clinical Medicine ·Dominik Koch, Malte Schirren, (unknown), Hanno Nieß, Bernhard W. Renz, (unknown), Markus Guba, Dionysios Koliogiannis	0
7	Importance of the neutrophil-to-lymphocyte ratio as a marker for microbiological specimens in critically ill patients after liver or lung transplantation 2024 ·Infection ·Steffen B. Wiegand, Michael Paal, Jette Jung, Markus Guba, Christian Lange, Christian Schneider, Nikolaus Kneidinger, (unknown), Michael Irlbeck, Michael Zöller	2
8	Imaging-Derived Biomarkers Integrated with Clinical and Laboratory Values Predict Recurrence of Hepatocellular Carcinoma After Liver Transplantation 2023 ·Journal of Hepatocellular Carcinoma ·(unknown), Philipp Schindler, (unknown), Max Masthoff, Mirjam Gerwing, P Beauvais, Enrico N. De Toni, Christian M. Lange, Jonel Trebicka, (unknown), Max Seidensticker, Jens Ricke, Andreas Pascher, Markus Guba, Michael Ingrisch, Moritz Wildgruber, Osman Öcal	3
9	Frequent Follow-Up of Delisted Liver Transplant Candidates Is Necessary: An Observational Study about Characteristics and Outcomes of Delisted Liver Transplant Candidates 2023 ·Journal of Clinical Medicine ·(unknown), Dionysios Koliogiannis, Markus Bo Schoenberg, Dominik Koch, (unknown), Gerald Denk, Markus Rehm, Simon Schäfer, Ursula Ehmer, Andreas E. Kremer, Bruno Meiser, Jens Werner, Markus Guba, Nikolaus Börner	1
10	Perivascular Tumor-Infiltrating Leukocyte Scoring for Prognosis of Resected Hepatocellular Carcinoma Patients 2019 ·HPB ·(unknown), Markus Bo Schoenberg, (unknown), Rainer Christoph Miksch, (unknown), Barbara Mayer, Markus Guba, Jens Werner	2
11	The center effect in liver transplantation in the Eurotransplant region: a retrospective database analysis 2018 ·Transplant International ·Joris J. Blok, Jacob D. de Boer, Hein Putter, Xavier Rogiers, Markus Guba, Christian P. Strassburg, Undine Samuel, Bart van Hoek, Jaap F. Hamming, Andries E. Braat	9
12	Extra-capsular growth of lymph node metastasis correlates with poor prognosis and high SOX9 expression in gastric cancer 2018 ·BMC Cancer ·(unknown), Martin K. Angele, (unknown), Petra Ganschow, (unknown), Markus Guba, Jens Werner, Thomas Kirchner, Jens Neumann	17
13	Shipping of split-livers results in a higher retransplantation rate but does not affect overall patient's survival : an analysis from the Eurotransplant liver follow-up registry 2017 ·Ghent University Academic Bibliography (Ghent University) ·Joachim Andrassy, Sebastian Wolf, Michael Lauseker, Martin K. Angele, Undine Samuel, Xavier Rogiers, Jens Werner, Markus Guba	1
14	Temporary Intra-Operative Portocaval Shunts, Post-Operative Infections, and Mid-Term Survival after Cava-Sparing Liver Transplantation 2017 ·Surgical Infections ·Maximilian Weniger, Joachim Andrassy, Thomas Weig, Béatrice Grabein, Alexander Crispin, Markus Rentsch, (unknown), Alexandr V. Bazhin, Jan DʼHaese, Werner Hartwig, Jens Werner, Markus Guba, Eugen Faist, Sebastian Pratschke, Martin K. Angele	2
15	Higher retransplantation rate following extended right split‐liver transplantation: An analysis from the eurotransplant liver follow‐up registry 2017 ·Liver Transplantation ·Joachim Andrassy, Sebastian Wolf, Michael Lauseker, Martin K. Angele, (unknown), Undine Samuel, Xavier Rogiers, Jens Werner, Markus Guba	18
16	Time‐dependent impact of age and comorbidities on long‐term overall survival after liver resection 2016 ·Liver International ·Tobias S. Schiergens, (unknown), Michael Thomas, Markus Rentsch, (unknown), (unknown), Helmut Küchenhoff, Serene M. L. Lee, Markus Guba, Jens Werner, Wolfgang E. Thasler	11
17	Pankreaskarzinom im hohen Alter: Leitlinien und individualisierte Therapie 2013 ·Chirurg ·Hanno Nieß, Axel Kleespies, Joachim Andrassy, (unknown), Martin K. Angele, Markus Guba, K.‐W. Jauch, C. Bruns	1
18	Pankreaskarzinom im hohen Alter 2013 ·Der Chirurg ·Hanno Nieß, Axel Kleespies, Joachim Andrassy, (unknown), Martin K. Angele, Markus Guba, K.‐W. Jauch, C. Bruns	9
19	Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer 2007 ·Angiogenesis ·Ivan Ischenko, Markus Guba, Maksim Yezhelyev, A. Papyan, Gerald Schmid, Tim Green, Michael Fennell, Karl‐Walter Jauch, Christiane J. Bruns	44
20	Inhibition of the mammalian target of rapamycin impedes lymphangiogenesis 2007 ·Kidney International ·Stephan Huber, Christiane J. Bruns, G. Schmid, Patrick Hermann, Claudius Conrad, (unknown), Ralf Huss, Christian Graeb, K.‐W. Jauch, Christopher Heeschen, Markus Guba	166

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact